Hempstract Stock Net Income
| HPSTDelisted Stock | USD 0.13 0.03 18.75% |
Hempstract's fundamental analysis aims to assess its intrinsic value by examining key economic and financial indicators - such as cash flow records, changes in balance sheet accounts, income statement trends, financial ratios, and relevant microeconomic factors affecting Hempstract Pink Sheet price.
Hempstract |
Hempstract Company Net Income Analysis
Hempstract's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Hempstract Net Income | (4.43 K) |
Most of Hempstract's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Hempstract is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Hempstract reported net income of (4,435). This is 100.0% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 100.0% higher than that of the company.
Hempstract Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Hempstract's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Hempstract could also be used in its relative valuation, which is a method of valuing Hempstract by comparing valuation metrics of similar companies.Hempstract is currently under evaluation in net income category among its peers.
Hempstract Fundamentals
| Return On Equity | -0.57 | |||
| Return On Asset | -0.0644 | |||
| Profit Margin | (0.35) % | |||
| Operating Margin | (0.40) % | |||
| Current Valuation | 2.33 M | |||
| Revenue | 12.56 K | |||
| Gross Profit | 1.7 K | |||
| Net Income | (4.43 K) | |||
| Cash And Equivalents | 9.57 K | |||
| Total Debt | 75 | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 1.16 X | |||
| Beta | -3.53 |
About Hempstract Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hempstract's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hempstract using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hempstract based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Hempstract Pink Sheet
If you are still planning to invest in Hempstract check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hempstract's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |